ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC33331-25mg |
|
315698-07-8 |
BRD 4354
|
0 | C21H23ClN4O | |
GC33331-10mg |
|
315698-07-8 |
BRD 4354
|
0 | C21H23ClN4O | |
GC33331-5mg |
|
315698-07-8 |
BRD 4354
|
0 | C21H23ClN4O | |
GC33330-10mg |
|
35730-78-0 |
Cynaropicrin
|
0 | C19H22O6 | |
GC33330-5mg |
|
35730-78-0 |
Cynaropicrin
|
0 | C19H22O6 | |
GC33329-10mg |
|
464924-27-4 |
SLLK, Control Peptide for TSP1 Inhibitor
|
0 | C21H41N5O6 | |
GC33329-5mg |
|
464924-27-4 |
SLLK, Control Peptide for TSP1 Inhibitor
|
0 | C21H41N5O6 | |
GC33329-1mg |
|
464924-27-4 |
SLLK, Control Peptide for TSP1 Inhibitor
|
0 | C21H41N5O6 | |
GC33328-1g |
|
1226-42-2 |
4,4’-Dimethoxybenzil (p-Anisil)
|
0 | C16H14O4 | |
GC33328-10mM(1mLinDMSO) |
|
1226-42-2 |
4,4’-Dimethoxybenzil (p-Anisil)
|
0 | C16H14O4 | |
GC33325-10mg |
|
1476074-39-1 |
VX-984 (M9831)
|
0 | C23H21D2N7O | |
GC33325-50mg |
|
1476074-39-1 |
VX-984 (M9831)
|
0 | C23H21D2N7O | |
GC33325-5mg |
|
1476074-39-1 |
VX-984 (M9831)
|
0 | C23H21D2N7O | |
GC33324-100mg |
|
1923851-49-3 |
GSK9311
|
0 | C24H31N5O3 | |
GC33324-50mg |
|
1923851-49-3 |
GSK9311
|
0 | C24H31N5O3 | |
GC33324-25mg |
|
1923851-49-3 |
GSK9311
|
0 | C24H31N5O3 | |
GC33324-10mg |
|
1923851-49-3 |
GSK9311
|
0 | C24H31N5O3 | |
GC33324-5mg |
|
1923851-49-3 |
GSK9311
|
0 | C24H31N5O3 | |
GC33324-2mg |
|
1923851-49-3 |
GSK9311
|
0 | C24H31N5O3 | |
GC33324-10mM(1mLinDMSO) |
|
1923851-49-3 |
GSK9311
|
0 | C24H31N5O3 | |